Aptevo Therapeutics: Funding, Investors & Team (Oct 2026)
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for cancer and blood disorders. They use a special technology called ADAPTIR™ to improve outcomes for cancer patients. The company is known for its supportive work environment, culture of innovation, and unique platform technology. As a result, Aptevo has been able to attract talented individuals with experience in other leading biotech companies such as Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
Aptevo Therapeutics has raised $90.3M across 9 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Jun 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aptevo Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Aptevo Therapeutics Funding Rounds
1 of 9 rounds was announced without a disclosed amount and is excluded from the total.
Aptevo Therapeutics raised $4.6M in an undisclosed round announced in Apr 2024.
5 months later, an undisclosed round of $3.0M was announced in Sep 2024.
3 months later, an undisclosed round of $6.2M was announced in Dec 2024.
4 months later, an undisclosed round of $2.0M was announced in Apr 2025.
2 months later, an undisclosed round of $8.0M was announced in Jun 2025.
7 months later, an undisclosed round of $60.0M was announced in Jan 2026.
4 months later, an undisclosed round was announced in May 2026 with no disclosed amount.
1 month later, an undisclosed round of $1.5M was announced in Jun 2026.
Aptevo Therapeutics Founders and Leadership Team
Contact details for the Aptevo Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Aptevo Therapeutics Funding Compared to Other Biotechnology Startups
Aptevo Therapeutics' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aptevo Therapeutics in Biotechnology and Seattle
Companies Similar to Aptevo Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Aptevo Therapeutics Funding FAQs
What does Aptevo Therapeutics do?
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for cancer and blood disorders. They use a special technology called ADAPTIR™ to improve outcomes for cancer patients. The company is known for its supportive work environment, culture of innovation, and unique platform technology. As a result, Aptevo has been able to attract talented individuals with experience in other leading biotech companies such as Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
How much funding has Aptevo Therapeutics raised?
Aptevo Therapeutics has raised $90.3M across 9 rounds on record. The most recent is an undisclosed round of $1.5M announced in Jun 2026.
When did Aptevo Therapeutics last raise funding?
Aptevo Therapeutics' most recent funding round on record is an undisclosed round of $1.5M, announced in Jun 2026.
Who founded Aptevo Therapeutics?
FundedIQ lists Marvin L White (Founder), Marvin White (Founder) at Aptevo Therapeutics.
Where is Aptevo Therapeutics headquartered?
Aptevo Therapeutics is based in Seattle, Washington, United States.
How many employees does Aptevo Therapeutics have?
Aptevo Therapeutics is in the 51-100 employee band.
How does Aptevo Therapeutics' funding compare to other Biotechnology startups?
Aptevo Therapeutics' latest round of $1.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Aptevo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aptevo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.